Laura Elo serves as Professor at the University of Turku and holds dual leadership roles as Research Director of Turku Bioscience Centre and Vice Director of Turku Life Science Center. She is a key figure in the InFLAMES Flagship research program focused on inflammation mechanisms. Her primary affiliation is with the Computational Biomedicine department where she leads the Elo Lab. Her research spans computational biomedicine with emphasis on proteomics, metabolomics, and machine learning applications in disease modeling. Key focus areas include longitudinal analysis of type 1 diabetes, obesity-related metabolic pathways, malaria resistance mechanisms, and single-cell immunology. She develops computational methods for cell migration analysis (CellRomeR package) and metagenomic data processing. Recent publications demonstrate strong interdisciplinary collaboration across bioinformatics, clinical medicine, and systems biology. Her work frequently appears in high-impact journals including Science , Scientific Reports , and American Journal of Physiology , with multiple 2025 publications highlighting cutting-edge computational approaches to complex diseases. Laura Elo actively disseminates research through platforms like Tekniikan Maailma (The World of Technology), making computational medicine accessible to broader audiences. Her leadership extends to organizing major events like the European Conference on Computational Biology (ECCB2024). The Elo Lab maintains strong industry and clinical partnerships, evidenced by large-scale studies using Nordic Arthroplasty Register data and collaborations with Turku Metabolomics Core. Current projects integrate multi-omics data with clinical outcomes to improve disease diagnosis and treatment prediction.